Hoodless P A, Ryan A K, Schrader T J, Deeley R G
Cancer Research Laboratories, Queen's University, Kingston, Ontario, Canada.
DNA Cell Biol. 1992 Dec;11(10):755-65. doi: 10.1089/dna.1992.11.755.
Although the avian apoVLDLII gene is normally expressed exclusively in the liver of the laying hen, the gene can be activated by estrogen in birds of either sex beginning between days 7-9 of embryogenesis. Developmentally programmed demethylation of sites in the 5'- and 3'-flanking regions of the gene have been shown to occur during this period of embryogenesis, suggesting that they may reflect changes in protein-DNA interactions that are involved in the acquisition of competence to activate the apoVLDLII gene. We have detected specific protein interactions at one location approximately 2.6 kb upstream from the apoVLDLII gene, that includes an Msp I site whose methylation status changes between days 7 and 9 of embryogenesis. The sequence of this region bears significant similarity to binding sites of members of the bZIP family of liver-enriched or -specific factors such as C/EBP, DBP, and LAP, that are characteristically produced relatively late during liver development. In the studies described here, we demonstrate that proteins binding to the upstream apoVLDLII site do not correspond to previously identified liver-enriched or -specific factors. They also display a pattern of activity during development and in human and avian hepatoma cell lines indicating that their expression is increased in proliferating cells. Southwestern blotting and UV cross-linking studies indicate that two proteins of approximately 60 kD are capable of binding to the site and we describe the purification of these factors from crude nuclear protein extracts obtained from rooster liver.
尽管禽类载脂蛋白VLDLII基因通常仅在产蛋母鸡的肝脏中表达,但在胚胎发育第7至9天开始,该基因可被雌激素激活,无论雌雄禽类均是如此。已证实在胚胎发育的这一时期,该基因5'和3'侧翼区域位点会发生发育程序性去甲基化,这表明它们可能反映了与获得激活载脂蛋白VLDLII基因能力相关的蛋白质-DNA相互作用的变化。我们在载脂蛋白VLDLII基因上游约2.6 kb处的一个位置检测到了特异性蛋白质相互作用,该位置包括一个Msp I位点,其甲基化状态在胚胎发育的第7天和第9天之间发生变化。该区域的序列与肝脏富集或特异性因子bZIP家族成员的结合位点具有显著相似性,如C/EBP、DBP和LAP,这些因子在肝脏发育过程中相对较晚产生。在本文所述的研究中,我们证明与载脂蛋白VLDLII基因上游位点结合的蛋白质与先前鉴定的肝脏富集或特异性因子并不对应。它们在发育过程中以及在人和禽类肝癌细胞系中也表现出一种活性模式,表明它们在增殖细胞中的表达增加。蛋白质免疫印迹法和紫外线交联研究表明,两种约60 kD的蛋白质能够结合到该位点,我们描述了从公鸡肝脏获得的粗核蛋白提取物中纯化这些因子的过程。